Hamid Hoveyda
Corporate Officer/Principal bei Ogeda SA
Profil
Hamid Hoveyda is currently the Director-Medical Chemistry at Ogeda SA since 2007.
Previously, he worked as a Principal at Affymax, Inc. and Tranzyme Pharma, Inc. (Canada).
Dr. Hoveyda holds a doctorate degree from the University of British Columbia.
Aktive Positionen von Hamid Hoveyda
Unternehmen | Position | Beginn |
---|---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Corporate Officer/Principal | 01.09.2007 |
Ehemalige bekannte Positionen von Hamid Hoveyda
Unternehmen | Position | Ende |
---|---|---|
Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | - |
AFFYMAX, INC. | Corporate Officer/Principal | - |
Ausbildung von Hamid Hoveyda
University of British Columbia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AFFYMAX, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Health Technology |
Tranzyme Pharma, Inc. (Canada) |